A Novel Multiplex Elisa Assay for Evaluating Patients with Gross Hematuria for Bladder Cancer.

Study ID
STU 092016-080

Cancer Related
Yes

Healthy Volunteers
No

Study Sites

  • Clements University Hospital
  • UT Southwestern Ambulatory Services

Contact
Allison Beaver
214/645-8788
ALLISON.BEAVER@UTSouthwestern.edu

Principal Investigator
Yair Lotan, M.D.

Summary

This is a phase 3 single arm study comparing the diagnostic capabilities of multiplex eLiSa assay to VuC and nMP22 BladderChek to reference standard of cystoscopy in participants with gross hematuria.

Participant Eligibility

Age 18 years or older
Have documented or reported gross hematuria within 3 month of study enrollment
Willing and able to give written informed consent